Synthesis of new 3-methylthio-5-aryl-4-isothiazolecarbonitriles with broad antiviral spectrum

被引:22
作者
Cutrì, CCC
Garozzo, A
Siracusa, MA
Castro, A
Tempera, G
Sarvà, MC
Guerrera, F
机构
[1] Univ Catania, Dept Pharmaceut Sci, I-95125 Catania, Italy
[2] Univ Catania, Dept Microbiol & Gynaecol Sci, I-95124 Catania, Italy
关键词
isothiazole derivatives; picornavirus; measles;
D O I
10.1016/S0166-3542(02)00072-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The isothiazole derivative 3-methylthio-5-(4-OBn-phenyl)-4-isothiazolecarbonitrile, coded IS-50, which in previous studies had exhibited a broad antipicornavirus spectrum of action, was selected as the model for the synthesis of a new series of 3-methylthio-5-aryl-4-isothiazolecarbonitriles. These compounds were prepared in good yield (from 66 to 82%) by alkylation of 3-methylthio-5-(4-hydroxyphenyl)-4-isothiazolecarbonitrile with suitable bromides in the presence of acetone; only the 4-cyanophenoxy derivatives were obtained in a yield of less than 30%. All the compounds were screened against a panel of 17 representative human rhinovirus (HRV) serotypes belonging to both A and B groups, enteroviruses polio 1, ECHO 9 and Coxsackie B1, cardiovirus EMC, measles virus, and herpes simplex virus type I (HSV-1). Our results demonstrate that HRV 86 (group A) and HRVs 39 and 89 (group B) are the rhinovirus serotypes more susceptible to the action of these compounds. Isothiazole derivatives with a longer intermediate alkyl chain exhibited good activity against polio 1 and ECHO 9. The compound bearing a butyl group between the two phenoxy rings showed the lowest IC50 against Coxsackie B1 and measles viruses. No activity against HSV-1 was detected with any of the compounds screened. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 29 条
[21]  
MCKINLAY MA, 1992, ANNU REV MICROBIOL, V46, P635, DOI 10.1146/annurev.micro.46.1.635
[22]   CONFORMATIONAL CHANGE IN THE FLOOR OF THE HUMAN RHINOVIRUS CANYON BLOCKS ADSORPTION TO HELA-CELL RECEPTORS [J].
PEVEAR, DC ;
FANCHER, MJ ;
FELOCK, PJ ;
ROSSMANN, MG ;
MILLER, MS ;
DIANA, G ;
TREASURYWALA, AM ;
MCKINLAY, MA ;
DUTKO, FJ .
JOURNAL OF VIROLOGY, 1989, 63 (05) :2002-2007
[23]   A NOVEL BASIS FOR CAPSID STABILIZATION BY ANTIVIRAL COMPOUNDS [J].
PHELPS, DK ;
POST, CB .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (04) :544-551
[24]   INVITRO ANTIVIRAL ACTIVITY OF 4 ISOTHIAZOLE DERIVATIVES AGAINST POLIOVIRUS TYPE-1 [J].
PINIZZOTTO, MR ;
GAROZZO, A ;
GUERRERA, F ;
CASTRO, A ;
LAROSA, MG ;
FURNERI, PM ;
GEREMIA, E .
ANTIVIRAL RESEARCH, 1992, 19 (01) :29-41
[25]  
ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587
[26]   Treatment of human enterovirus infections [J].
Rotbart, HA ;
O'Connell, JF ;
McKinlay, MA .
ANTIVIRAL RESEARCH, 1998, 38 (01) :1-14
[27]  
SHADBOLT RS, 1971, J MED CHEM, V14, P836
[28]   PRINCIPAL PROPERTIES FOR AROMATIC SUBSTITUENTS - A MULTIVARIATE APPROACH FOR DESIGN IN QSAR [J].
SKAGERBERG, B ;
BONELLI, D ;
CLEMENTI, S ;
CRUCIANI, G ;
EBERT, C .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1989, 8 (01) :32-38
[29]  
WALSH RJA, 1972, J CHEM SOC P1, V1, P1247